title: Low-dose aspirin is associated with an increased risk of haemorrhage; but not in people with diabetes who have a high baseline rate of bleeding.
abstract: Implications for practice and research: Low-dose aspirin (≤ 300 mg/day) increases the risk of major bleeding. Individuals with diabetes have a higher risk of bleeding independent of aspirin exposure. Future work should include comparative effectiveness studies to help inform treatment strategies based on individual risks, benefits, patient preferences and values.
authors.affiliation: Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. sbutalia@ucalgary.ca
authors.forename: Sonia
authors.initials: S
authors.lastname: Butalia
authors.forename: Alexander A
authors.initials: AA
authors.lastname: Leung